Keros Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of KROS for the last quarter is 143.00 k USD, and it's 1687.50% higher compared to the previous quarter. The net income of Q4 23 is -40.24 M USD.